Matthew Goldfarb - 06 May 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
Director
Signature
Jonathan B. Leiken, Attorney-in-fact for Matthew Goldfarb
Issuer symbol
DBD
Transactions as of
06 May 2022
Net transactions value
$0
Form type
4
Filing time
10 May 2022, 16:55:55 UTC
Previous filing
16 Nov 2021
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Award $0 +30,928 +35% $0.000000 119,227 06 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes restricted stock units.